(Q41579230)

4 October 2017

Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome (English)

1 reference

4 October 2017

Guillain–Barré syndrome

0 references

author

Chih-Hsiang Chang

3

0 references

author name string

Jui-Hsiang Lin

1

1 reference

4 October 2017

Kun-Hua Tu

2

1 reference

4 October 2017

Chih-Hsiang Chang

3

1 reference

4 October 2017

Yung-Chang Chen

4

1 reference

4 October 2017

Ya-Chung Tian

5

1 reference

4 October 2017

Chun-Chen Yu

6

1 reference

4 October 2017

Cheng-Chieh Hung

7

1 reference

4 October 2017

Ji-Tseng Fang

8

1 reference

4 October 2017

Chih-Wei Yang

9

1 reference

4 October 2017

Ming-Yang Chang

10

1 reference

4 October 2017

17 December 2014

1 reference

Transfusion and Apheresis Science

4 October 2017

1 reference

4 October 2017

52

1 reference

4 October 2017

1

1 reference

4 October 2017

78-83

1 reference

Guillain-Barré syndrome (GBS).

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barré syndrome: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Clinico-electrophysiological findings and prognosis of Guillain-Barré syndrome--10 years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Immunotherapy for Guillain-Barre syndrome: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Therapeutic plasma exchange: core curriculum 2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Powikłania u chorych leczonych metodą plazmaferezy na oddziale intensywnej terapii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Complications of therapeutic plasma exchange: a recent assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Controlled trial prednisolone in acute polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Outcome and its predictors in Guillain-Barre syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Plasmapheresis therapy in renal transplant patients: five-year experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

A clinical prognostic scoring system for Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Early recognition of poor prognosis in Guillain-Barre syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barré syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Haemophilus influenzae infection and Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barre syndrome and SIADH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Guillain-Barré syndrome and hyponatraemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Therapeutic plasma exchange: complications and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.12.005

10.1016/J.TRANSCI.2014.12.005

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference